CClinicalTrials.gg
Not yet recruitingNCT07845383Updated Sep 28, 2026

Bite Sized Biomarkers

An interventional study of Bite-sized Biomarkers: Skin carotenoid scores in Dietary Assessment, Diet, Food, and Nutrition and Carotenoid Status, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Stanford University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary objective of this study is to rigorously evaluate the effectiveness of a Food is Medicine (FIM) intervention using objective biomarkers and to determine the role of nutritional monitoring on the impact and sustainability of integrating nutrition supports into primary care.

Read the detailed description

A critical research gap of FIM is objective, non-invasive measures of dietary intake for rigorously evaluating interventions, such as produce prescription programs. The Veggie Meter® is a research-grade tool strongly correlated with plasma carotenoid levels that utilizes pressure-mediated reflection spectroscopy to rapidly detect carotenoids in the skin, correcting for melanin concentration across skin tones, to estimate V/F intake over 30 days. Carotenoids are fat-soluble compounds found ubiquitously in V/F, detectable in the diet, plasma, and body tissues and may contain bioactive properties that have been demonstrated to slow the progression of chronic disease development. Carotenoid status may serve as a comprehensive, objective, and non-invasive measures of dietary intake that has yet to be implemented in the evaluation of FIM. In addition to being ideally suited for evaluating the effectiveness of FIM, the Veggie Meter® may serve as a promising tool to incorporate into primary care for better assessing dietary intake for prevention and treatment of diet-related chronic diseases. With dietary intake and behavioral lifestyle modifications at the core of chronic disease management, understanding the role of nutritional monitoring in primary care on initiating and sustaining patient health-related behavior change is essential to reduce disease prevalence and severity.

The specific aims of the project are:

Aim 1: Evaluate whether participants in a FIM intervention have higher skin carotenoid scores compared to those not in a FIM intervention over 6 months.

Aim 2: Determine whether informing participants of their skin carotenoid scores at baseline is effective for increasing diet quality at 6 months compared to not receiving skin carotenoid scores. Participants and controls (n=150) will be randomized to receive skin carotenoid scores and their clinical lab values (HbA1c, lipids, BP, anthropometrics) or to only receive their clinical lab values.

Aim 3: Examine barriers and facilitators of integrating objective, non-invasive nutritional monitoring into primary care using a convergent mixed methods design.

02

Conditions studied

  • Dietary Assessment
  • Diet, Food, and Nutrition
  • Carotenoid Status

Keywords

  • Skin carotenoids
  • Food is Medicine
  • Nutritional monitoring
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • adults (18 years or older)
  • at risk for food insecurity (affirmative response to one or more questions on the Huger Vital Signs
  • at risk or experiencing a nutrition-sensitive chronic conditions (e.g., obesity, type 2 diabetes, MASLD, hypertension, etc.)
  • able to read and write in English or Spanish

Exclusion criteria

Exclusion Criteria:

  • planned relocation within the study window
  • currently pregnant or plans to become pregnant within the study window
  • unable to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Bite-sized Biomarkers: Knowledge of skin carotenoid scores

    Participants will be randomized to receive their skin carotenoid scores at baseline.

    Behavioral: Bite-sized Biomarkers: Skin carotenoid scores

  • Active comparator
    Bite-sized Biomarkers: Masked to Skin Carotenoid Scores

    Participants will be randomized to be masked to their skin carotenoid values until the follow-up visit.

    Behavioral: Bite-sized Biomarkers: Skin carotenoid scores

Interventions

  • BehavioralBite-sized Biomarkers: Skin carotenoid scores

    In this intervention, participants will be randomized to either receive or be masked to additional information on their nutritional status by measuring skin carotenoid scores as a proxy of fruit and vegetable intake to see if knowledge of status at baseline leads to more dietary behavior change.

05

What researchers measure

Primary outcomes

  1. Skin carotenoid scores

    Change in skin carotenoid scores measured using pressure-mediated reflection spectroscopy (Veggie Meter)

    Time frame: Baseline, 12-weeks, and 6-months.

Secondary outcomes

  1. Dietary Intake

    Dietary intake will be calculated using the Healthy Eating Index (HEI)-2020

    Time frame: Baseline, 6-months

  2. Depression

    Symptoms of depression will be measured using the 9-item Patient Health Questionnaire (PHQ-9)

    Time frame: Baseline, 6-months

  3. Anxiety

    Symptoms of anxiety will be measured using the 7-item Generalized Anxiety Disorder (GAD-7).

    Time frame: Baseline, 6-month

  4. Food security status

    Food security status will be measured using the USDA Adult Food Security Survey Module

    Time frame: Baseline, 6-months

  5. Nutrition security status

    The Center for Nutrition and Health Impact 4-item nutrition security screener will be used.

    Time frame: Baseline, 6-months

06

Study locations

1 site
  • Stanford University
    Palo Alto, California 94114, United States
07

References and documents

Individual participant data

Plan to share: No — To protect participant anonymity, individual participant data is not expected to be shared with other researchers.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07845383
Lead sponsor
Stanford University
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Marcela Radtke (Postdoctoral Research Fellow, Stanford University) — Principal investigator
First posted
Sep 28, 2026
Start date
Oct 5, 2026 (estimated)
Primary completion
Jun 30, 2028 (estimated)
Completion
Jul 28, 2028 (estimated)
Last update
Sep 28, 2026

Study contacts

Marcela Radtke, PhD
Contact
mdradtke@stanford.edu
650-260-4767

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion